Cetera Investment Advisers’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
33,532
+10,785
| +47% | +$101K | ﹤0.01% | 3352 |
|
|
2025
Q1 | $162K | Buy |
22,747
+9,599
| +73% | +$68.2K | ﹤0.01% | 3660 |
|
|
2024
Q4 | $153K | Sell |
13,148
-4,788
| -27% | -$55.8K | ﹤0.01% | 3495 |
|
|
2024
Q3 | $369K | Sell |
17,936
-4,731
| -21% | -$97.2K | ﹤0.01% | 2895 |
|
|
2024
Q2 | $507K | Sell |
22,667
-26,286
| -54% | -$588K | ﹤0.01% | 2580 |
|
|
2024
Q1 | $1.35M | Buy |
+48,953
| New | +$1.35M | ﹤0.01% | 1843 |
|
|
2022
Q2 | – | Sell |
-2,915
| Closed | -$212K | – | 1900 |
|
|
2022
Q1 | $212K | Sell |
2,915
-141
| -5% | -$10.3K | ﹤0.01% | 1675 |
|
|
2021
Q4 | $361K | Buy |
3,056
+25
| +0.8% | +$2.95K | 0.01% | 1382 |
|
|
2021
Q3 | $407K | Sell |
3,031
-256
| -8% | -$34.4K | 0.01% | 1257 |
|
|
2021
Q2 | $532K | Buy |
+3,287
| New | +$532K | 0.01% | 1092 |
|